Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 332.38% | -93.89% | -163.58% | -179.56% | -202.51% |
| Total Depreciation and Amortization | 6.76% | 7.76% | 5.48% | 5.32% | 3.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.75% | 235.61% | 294.84% | 365.34% | 479.59% |
| Change in Net Operating Assets | 66.75% | -281.66% | 124.65% | 106.59% | 17.30% |
| Cash from Operations | 26.23% | -14.40% | -2.88% | 19.50% | 22.63% |
| Capital Expenditure | -37.01% | -43.13% | -54.20% | -58.41% | -79.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.64% | 10.22% | -32.16% | -134.38% | 120.90% |
| Cash from Investing | 71.88% | -200.49% | -197.12% | -524.60% | -31.21% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 23.97% | 97.71% | -28.88% | -28.88% | -4,274.19% |
| Issuance of Common Stock | 353.40% | 308.55% | 422.69% | 57.25% | 20.99% |
| Repurchase of Common Stock | 66.03% | 38.87% | 45.77% | 56.66% | 10.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.11% | 81.22% | -4,356.62% | -1,238.19% | -76.51% |
| Foreign Exchange rate Adjustments | -110.79% | 157.46% | 490.21% | 75.36% | 520.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 359.08% | -104.20% | -212.62% | -201.09% | -325.77% |